122 related articles for article (PubMed ID: 35647653)
21. [The development of novel tumor targeting delivery strategy].
Gao HL; Jiang XG
Yao Xue Xue Bao; 2016 Feb; 51(2):272-80. PubMed ID: 29856581
[TBL] [Abstract][Full Text] [Related]
22. Positively charged helical chain-modified stimuli-responsive nanoassembly capable of targeted drug delivery and photoacoustic imaging-guided chemo-photothermal synergistic therapy.
Zhang J; Qiao Z; Liu HY; Song J; Yin J
Biomater Sci; 2019 Apr; 7(5):2050-2060. PubMed ID: 30847457
[TBL] [Abstract][Full Text] [Related]
23. Hierarchically stimuli-responsive nanovectors for improved tumor penetration and programed tumor therapy.
Liu J; Guo X; Luo Z; Zhang J; Li M; Cai K
Nanoscale; 2018 Jul; 10(28):13737-13750. PubMed ID: 29992216
[TBL] [Abstract][Full Text] [Related]
24. Dual-responsive core-crosslinked polyphosphoester-based nanoparticles for pH/redox-triggered anticancer drug delivery.
Sun Y; Du X; He J; Hu J; Zhang M; Ni P
J Mater Chem B; 2017 May; 5(20):3771-3782. PubMed ID: 32264066
[TBL] [Abstract][Full Text] [Related]
25. Beyond hydrophilic polymers in amphiphilic polymer-based self-assembled NanoCarriers: Small hydrophilic carboxylate-capped disulfide drug delivery system and its multifunctionality and multispatial targetability.
Choi YS; Cho H; Choi WG; Lee SS; Huh KM; Shim MS; Park IS; Cho YY; Lee JY; Lee HS; Kang HC
Biomaterials; 2022 Jan; 280():121307. PubMed ID: 34894582
[TBL] [Abstract][Full Text] [Related]
26. Targeting tumor hypoxia with stimulus-responsive nanocarriers in overcoming drug resistance and monitoring anticancer efficacy.
Xie Z; Guo W; Guo N; Huangfu M; Liu H; Lin M; Xu W; Chen J; Wang T; Wei Q; Han M; Gao J
Acta Biomater; 2018 Apr; 71():351-362. PubMed ID: 29545193
[TBL] [Abstract][Full Text] [Related]
27. Fabrication of dendrimer-releasing lipidic nanoassembly for cancer drug delivery.
Sun Q; Ma X; Zhang B; Zhou Z; Jin E; Shen Y; Van Kirk EA; Murdoch WJ; Radosz M; Sun W
Biomater Sci; 2016 Jun; 4(6):958-69. PubMed ID: 27087640
[TBL] [Abstract][Full Text] [Related]
28. Dual cellular stimuli-responsive hydrogel nanocapsules for delivery of anticancer drugs.
Yi Q; Ma J; Kang K; Gu Z
J Mater Chem B; 2016 Jul; 4(28):4922-4933. PubMed ID: 32263151
[TBL] [Abstract][Full Text] [Related]
29. Integrin-targeted pH-responsive micelles for enhanced efficiency of anticancer treatment in vitro and in vivo.
Liu J; Deng H; Liu Q; Chu L; Zhang Y; Yang C; Zhao X; Huang P; Deng L; Dong A; Liu J
Nanoscale; 2015 Mar; 7(10):4451-60. PubMed ID: 25679795
[TBL] [Abstract][Full Text] [Related]
30. Matrix metalloproteinase-sensitive size-shrinkable nanoparticles for deep tumor penetration and pH triggered doxorubicin release.
Ruan S; Cao X; Cun X; Hu G; Zhou Y; Zhang Y; Lu L; He Q; Gao H
Biomaterials; 2015 Aug; 60():100-10. PubMed ID: 25988725
[TBL] [Abstract][Full Text] [Related]
31. Fluorescent carbon dot-gated multifunctional mesoporous silica nanocarriers for redox/enzyme dual-responsive targeted and controlled drug delivery and real-time bioimaging.
Wang Y; Cui Y; Zhao Y; He B; Shi X; Di D; Zhang Q; Wang S
Eur J Pharm Biopharm; 2017 Aug; 117():105-115. PubMed ID: 28363599
[TBL] [Abstract][Full Text] [Related]
32. Co-delivery of PLK1-specific shRNA and doxorubicin via core-crosslinked pH-sensitive and redox ultra-sensitive micelles for glioma therapy.
Wang P; Yu N; Wang Y; Sun H; Yang Z; Zhou S
J Mater Chem B; 2018 Jan; 6(1):112-124. PubMed ID: 32254199
[TBL] [Abstract][Full Text] [Related]
33. Disulfide-Cross-Linked Nanogel-Based Nanoassemblies for Chemotherapeutic Drug Delivery.
Campea MA; Lofts A; Xu F; Yeganeh M; Kostashuk M; Hoare T
ACS Appl Mater Interfaces; 2023 May; 15(21):25324-25338. PubMed ID: 37192117
[TBL] [Abstract][Full Text] [Related]
34. pH-Responsive size-shrinkable mesoporous silica-based nanocarriers for improving tumor penetration and therapeutic efficacy.
He Y; Fan X; Wu X; Hu T; Zhou F; Tan S; Chen B; Pan A; Liang S; Xu H
Nanoscale; 2022 Jan; 14(4):1271-1284. PubMed ID: 35006226
[TBL] [Abstract][Full Text] [Related]
35. Smart pH/Redox Dual-Responsive Nanogels for On-Demand Intracellular Anticancer Drug Release.
Yang H; Wang Q; Huang S; Xiao A; Li F; Gan L; Yang X
ACS Appl Mater Interfaces; 2016 Mar; 8(12):7729-38. PubMed ID: 26960600
[TBL] [Abstract][Full Text] [Related]
36. Fabrication Of Dual pH/redox-Responsive Lipid-Polymer Hybrid Nanoparticles For Anticancer Drug Delivery And Controlled Release.
Men W; Zhu P; Dong S; Liu W; Zhou K; Bai Y; Liu X; Gong S; Zhang CY; Zhang S
Int J Nanomedicine; 2019; 14():8001-8011. PubMed ID: 31632014
[TBL] [Abstract][Full Text] [Related]
37. Biocompatible graphene oxide nanoparticle-based drug delivery platform for tumor microenvironment-responsive triggered release of doxorubicin.
Zhao X; Liu L; Li X; Zeng J; Jia X; Liu P
Langmuir; 2014 Sep; 30(34):10419-29. PubMed ID: 25109617
[TBL] [Abstract][Full Text] [Related]
38. Transforming Complexity to Simplicity: Protein-Like Nanotransformer for Improving Tumor Drug Delivery Programmatically.
Xiong H; Wang Z; Wang C; Yao J
Nano Lett; 2020 Mar; 20(3):1781-1790. PubMed ID: 32091222
[TBL] [Abstract][Full Text] [Related]
39. HPMA Polymeric Nanocarriers for Anticancer Drugs with Tumor Microenvironment-Responsive Extracellular Biodegradation and Intracellular Drug Release.
Zhou M; Tang M; Zhang H; Luo K; Huang Y
J Biomed Nanotechnol; 2019 Aug; 15(8):1688-1700. PubMed ID: 31219013
[TBL] [Abstract][Full Text] [Related]
40. Dual stimuli-responsive nanocarriers based on polyethylene glycol-mediated schiff base interactions for overcoming tumour chemoresistance.
Wei D; Tong Q; An Q; Ma X; Jiang X; Li X; Yi Z
Colloids Surf B Biointerfaces; 2022 May; 213():112408. PubMed ID: 35168105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
